Partow Kebriaei

Department of Stem Cell Transplantation and Cellular Therapy, U.T. MD Anderson Cancer Center

Affiliated withU.T. MD Anderson Cancer Center

Research Area

Biography

Partow Kebriaei has not added Biography.
If you are Partow Kebriaei and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 53	2013

Other Publications

Article	Year
Acute lymphoblastic leukaemia: diagnosis and classification. Best practice & research. Clinical haematology\| PubMed ID: 12617866	2002
Progress and challenges in the therapy of adult acute lymphoblastic leukemia. Current opinion in hematology\| PubMed ID: 12799534	2003
Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation. Leukemia research\| PubMed ID: 15068908	2004
Cytokines in the treatment of acute leukemias. Cancer treatment and research\| PubMed ID: 16209072	2005
Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma. British journal of haematology\| PubMed ID: 16681642	2006
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabin... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 17382251	2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity. Cancer\| PubMed ID: 17559140	2007
Biphenotypic acute leukaemia: a case series. British journal of haematology\| PubMed ID: 17593028	2007
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia. Blood\| PubMed ID: 17652620	2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 17697969	2007
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, a... Leukemia & lymphoma\| PubMed ID: 18297531	2008
Secondary myelodysplastic syndrome in a patient with Philadelphia-positive acute lymphoblastic leukemia after achieving a major molecular response with hyperCVAD plus imatinib mesylate. Leukemia research\| PubMed ID: 18355919	2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell t... British journal of haematology\| PubMed ID: 18564354	2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxoru... Cancer\| PubMed ID: 19090005	2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia. Cancer\| PubMed ID: 19235255	2009
Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma. American journal of hematology\| PubMed ID: 19384931	2009
非格司亭诱导干细胞动员后事先来那度胺与多发性骨&#x9AD... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 19450756	2009
Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 19539208	2009
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 19539211	2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood\| PubMed ID: 19654407	2009
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era. Clinical lymphoma & myeloma\| PubMed ID: 19778850	2009
Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology/oncology clinics of North America\| PubMed ID: 19825452	2009
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Human gene therapy\| PubMed ID: 19905893	2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20178853	2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies. Cancer research\| PubMed ID: 20424114	2010
Modern treatment programs for adults with acute lymphoblastic leukemia. Current hematologic malignancy reports\| PubMed ID: 20425366	2007
First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood\| PubMed ID: 20466853	2010
A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells. Biomedical microdevices\| PubMed ID: 20574820	2010
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20674757	2011
Clofarabine Â± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20946966	2011
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatc... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 20969970	2011
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutation... Blood\| PubMed ID: 21156844	2011
MSCs in hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21195306	2011
Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy\| PubMed ID: 21231805	2011
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth t... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21338705	2011
Persistence of cytogenetic abnormalities at complete remission after induction in patients with acute myeloid leukemia: prognostic significance and the potential role of allogeneic stem-cell... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21555694	2011
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer research\| PubMed ID: 21558388	2011
Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21684343	2011
Evaluation and management of BK virus-associated nephropathy following allogeneic hematopoietic cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21767514	2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21767516	2011
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitor... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 21867666	2012
High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation. American journal of hematology\| PubMed ID: 21948087	2011
Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant. Leukemia & lymphoma\| PubMed ID: 21988645	2012
Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 22035758	2011
Infusing CD19-Directed T Cells to Augment Disease Control in Patients Undergoing Autologous Hematopoietic Stem-Cell Transplantation for Advanced B-Lymphoid Malignancies. Human gene therapy\| PubMed ID: 22107246	2012
CARs: driving T-cell specificity to enhance anti-tumor immunity. Frontiers in bioscience (Scholar edition)\| PubMed ID: 22202074	2012
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas. Journal of blood medicine\| PubMed ID: 22282683	2010
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. The lancet oncology\| PubMed ID: 22357140	2012
The role of allogeneic hematopoietic stem cell transplantation in the therapy of patients with acute lymphoblastic leukemia. Current hematologic malignancy reports\| PubMed ID: 22410763	2012
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood\| PubMed ID: 22535661	2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results. Blood\| PubMed ID: 22586182	2012
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22643322	2012
Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease. Frontiers in oncology\| PubMed ID: 22655232	2011
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22750645	2012
Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22796535	2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 22982533	2013
Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size. Journal of biopharmaceutical statistics\| PubMed ID: 23075018	2012
Autologous Stem Cell Transplantation for Refractory orÂ Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of theÂ Specific High-Dose Chemotherapy Regimen onÂ Outcome. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 23128322	2012
Dose Intensification of Busulfan in the Preparative Regimen is Associated with Improved Survival: A Phase I/II Controlled, Randomized Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 23220013	2012
CARs in Chronic Lymphocytic Leukemia - Ready to Drive. Current hematologic malignancy reports\| PubMed ID: 23225251	2012
Cord-blood engraftment with ex vivo mesenchymal-cell coculture. The New England journal of medicine\| PubMed ID: 23234514	2012
Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 23313065	2013
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. British journal of haematology\| PubMed ID: 23330820	2013